Search Results - "Hunter, Chanelle"

Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer by Napier, Tiara S, Hunter, Chanelle L, Song, Patrick N, Larimer, Benjamin M, Sorace, Anna G

“…Advancements in monitoring and predicting of patient-specific response of triple negative breast cancer (TNBC) to immunotherapy (IMT) with and without…”
Get full text

Chemokine receptor PET imaging: Bridging molecular insights with clinical applications by Hunter, Chanelle, Larimer, Benjamin

“…Chemokine receptors are important components of cellular signaling and play a critical role in directing leukocytes during inflammatory reactions. Their…”
Get full text

92418 Molecular imaging of the tumor microenvironment to predict response to combination treatment with immunotherapy in triple negative breast cancer by Napier, Tiara S., Hunter, Chanelle L., Song, Patrick N., Larimer, Benjamin M., Sorace, Anna G.

“…ABSTRACT IMPACT: Insights from this project will provide clinical guidance in treatment of immunotherapy in triple negative breast cancer and identify early…”
Get full text

Abstract PS3-07: Molecular imaging of hypoxia and granzyme B alterations during combination treatment with immunotherapy in triple negative breast cancer by Napier, Tiara S., Hunter, Chanelle L., Song, Patrick N., Larimer, Ben M., Sorace, Anna G.

“…Background: Although a portion of triple negative breast cancer (TNBC) is sensitive to chemotherapeutic treatment with agents such as paclitaxel (PTX),…”
Get full text

Evaluation of 89ZrZr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer by Ducharme, Maxwell, Hall, Lucinda, Eckenroad, Whitney, Cingoranelli, Shelbie J, Houson, Hailey A, Jaskowski, Luke, Hunter, Chanelle, Larimer, Benjamin M, Lapi, Suzanne E

“…One of the most aggressive forms of breast cancer involves the overexpression of human epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in ∼25%…”
Get full text

Evaluation of [89Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer by Ducharme, Maxwell, Hall, Lucinda, Eckenroad, Whitney, Cingoranelli, Shelbie J., Houson, Hailey A., Jaskowski, Luke, Hunter, Chanelle, Larimer, Benjamin M., Lapi, Suzanne E.

“…One of the most aggressive forms of breast cancer involves the overexpression of human epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in ∼25%…”
Get full text